1. Home
  2. Infectious disease topics
  3. A–Z disease list
  4. Seasonal influenza
  5. Prevention and control
  6. Seasonal influenza vaccines
  7. Influenza vaccine effectiveness

Influenza vaccine effectiveness

Vaccine effectiveness is an estimate of the likelihood that a vaccine prevents influenza infection when used in everyday practice. To establish how well influenza vaccines work each season, influenza vaccine effectiveness is measured in observational studies.

In EU/EEA, the ECDC founded network I-MOVE (Influenza - Monitoring Vaccine Effectiveness) is responsible for measuring the vaccine effectiveness.

The studies provide country-specific and pooled effectiveness results for influenza vaccines authorised and used in EU/EEA Member States. The results are presented by age group and by different influenza vaccine strain. Since the influenza season 2012/13 results from observational studies assessing LAIV (Live attenuated influenza vaccine) used in children are available.

In general, a vaccine effectiveness of ~30-60% has been estimated for the three different influenza A (H1N1, H3N2) and B strains (Victoria or Yamagata lineages).

In Europe influenza vaccine effectiveness studies were initiated by ECDC and have been followed systematically since the influenza season 2008/2009.

Table: Overview of articles on effectiveness of inactivated seasonal influenza vaccines estimated in multi-center studies conducted by the I-MOVE network in Europe

Season  Author  Article
Season 2016-17 Kissling et al Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.
Season 2015-16 Kissling et al 2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children
Season 2014-2015 Valenciano et al Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Season 2013-2014 Valenciano et al The European I-MOVE Multicentre 2013-2014 Case-Control Study.  Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogeneous results by country against A(H3N2).
Season 2012-2013 Kissling et al Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicenter case-control study, influenza  season 2012/13
Season 2011-2012 Kissling et al

Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case–control study
Season 2010-2011 Kissling et al Overall and stratified estimates of influenza vaccine effectiveness in Europe for the season 2010-2011
Season 2008-2009 Kissling et al I-MOVE” towards monitoring seasonal and pandemic influenza accine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe 2008-9  

 

The live attenuated influenza vaccines used in paediatric programmes in Finland, Germany and United Kingdom have also been evaluated:

Season  Author  Article
Season 2016/17 Pebody et al End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17
Season 2015/16 Pebody et al Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season
Season 2015/16 Nohynek et al Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds – a nationwide cohort study Finland, influenza season 2015/16
Season 2014/15 Pebody et al Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15
Season 2012/13 Helmeke et al Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study

 

Read more

The I-MOVE in Europe (Influenza - Monitoring Vaccine Effectiveness) network
List of all publications on vaccine effectiveness published by the I-MOVE network

ECDC Study protocols for influenza vaccine effectiveness studies

See all updates on vaccine defectiveness